Archive | Fundraising RSS feed for this section

Healthtech Partnering Week: Meet the Panelists!

25 Feb

By Rory McCann, Marketing Manager & Conference Producer, LSN

Healthtech Partnering Week (HPW) launches in a few weeks and we want to highlight our esteemed panel faculty coming together to share the latest insights in early-stage life science and healthcare. Each panel is structured to tackle a variety of concerns relevant to fundraising executives that are timely and relevant to each major sector, and even specific indications.

Click the panelist photo below to learn more about their panel participation and to sign up for HPW!


Sascha Berger
TVM Capital Life Science

Jean Anne Booth
UnaliWear Inc.

Nat Brinn
VC23

Ivan Burkov
INKEF Capital

Barbara Clarke
The Impact Sea

Evan Cohen
Healthbox

Michele Colucci
DigitalDx Ventures

Marina Cortes
Hike Ventures LLC

Terence Craig
The Impact Seat

Ruchi Dana
DANA Group of Companies

Anne DeGheest
HealthTech Capital

Bettina Ernst
BERNINA BioInvest

Howard Fillit
Alzheimers Drug Discovery Foundation

Mary Furlong
Mary Furlong & Associates

Robert Garber
7wire Ventures

Amit Garg
Tau Ventures

Scott Gazelle
GreyBird Ventures

Tom Gibbs
Debiopharm Innovation Fund

Sam Goldberger
Ambit Health Ventures

Mark Gray
Constant Companion

Chris Haskell
Bayer

Katherine Hill Ritchie
Nottingham Spirk Family Office

Richard Hughen
Linshom

Alicia Irurzun-Lafitte
UCB Ventures

Stephen Johnston
Aging2.0

Kobus Jooste
Syllable

Arnd Kaltofen
VI Partners

Justin Kelly
AXA Venture Partners

Chris Kent
ODS Medical Inc.

Oliver Keown
Intuitive Surgical

Lily Kim
OS Fund

Kristin King
Boston Harbor Angels

Richard Kivel
GrayBella Capital

Daniella Kranjac
Dynamk Capital

David Lapointe
Optina Diagnostics

Thierry Laugel
Kurma Partners

Taja Lester
Health Equity Capital

George Li
Proxima Ventures

Lisa Mendoza
Bayer

Andy Merken
Burns & Levinson

Junaid Mian
SP8CEVC

Neal Mody
Zoic Capital

Richard Morphy
Parkinson's UK

Richard Mulry
Northwell Ventures

Jonathan Ng
Iterative Scopes

Laurie Orlov
Aging and Health Technology

Martin Pfister
High-Tech Gründerfonds

Stephen Pitt
Johnson & Johnson Innovation

Varun Ramdevan
Johnson & Johnson Innovation

Meghana Rao
Johnson & Johnson Innovation

David Rhew
Microsoft

João Ribas
Novo Holdings A/S

Jeffrey Ries
Healthbox

Christopher Rowan
Cove Fund

Florence Rozen
Fonds de solidarité FTQ

Kerry Rupp
True Wealth Ventures

Chirag Shah
Define Ventures

Todd Smith
OdessaConnect

Sherri Snelling
Caregiving Club

Patrik Sobocki
Industrifonden

Catello Somma
TVM Capital Life Science

Weiyong Sun
Daiichi Sankyo

Hung-Loi (Lloyd) Tran
Transpacific Venture Capital Partners

Rick Voight
Vivid-Pi

Tad Weems
Agilent Technologies

Mishael Zohar
OrbiMed Advisors LLC

Khat Zorig
Innospark Ventures

Meghan Zubradt
Johnson & Johnson Innovation

Life Science Nation and YAFO Capital Announce ACCESS CHINA Forum (Spring 2021) – China Innovation Out-Licensing Event at Healthtech Partnering Week

25 Feb

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

In 2021, Life Science Nation (LSN) launched the digital Healthtech Partnering Week (HPW), which consists of the renowned digital Redefining Early Stage Investments (RESI) 3-day event, 4D Meets AI 2-day event, and the Longevity, Health & Innovation (LHI) 2-day event, and now introducing ACCESS CHINA 2-day forum. LSN introduced this new open-concept conference theme in order that other independent conferences could participate in the week-long event with access to LSN’s premier partnering capability, which matches early-stage companies with strategic investment and licensing partners. HPW welcomes global partnering events to leverage the LSN global partner network, providing an incredible value to all attendees.

YAFO Capital‘s ACCESS CHINA Forum is a quarterly corporate access event series between China and Western biopharma. It is a leading deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market, and for Chinese companies to enter the global market. ACCESS CHINA Spring Forum, which focuses on China biotech innovation and out-licensing opportunities, adds to the HPW momentum. The Forum creates a great opportunity for LSN’s buy-side global partner network of investors, pharma and corporate strategics seeking equity and licensing opportunities to look at elite technology assets coming out of Asia. The scientist-entrepreneurs and fundraising CEOs coming to HPW via ACCESS CHINA Forum will be able to make new connections with global partners that will help them transition from their regional markets to the global arena.

LSN welcomes any firm that has a standalone life science partnering event happening simultaneously with HPW to join forces. YAFO Capital’s ACCESS CHINA Forum is a great example of how we can work together and deliver elite technology assets to a broader investor and strategic partner audience. Our goal is to reach across borders and events to raise the tide of early-stage partnering and lift all fundraising efforts in order to advance the latest in life-saving technologies and healthcare treatments.

Sign up to join Healthtech Partnering Week and take advantage of our global network of partners!

Free Webinar: Strategies for Successful Partnering

25 Feb

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Life Science Nation (LSN) has recently held two free webinars outlining strategies for successful partnering. Whether new to LSN and our early stage partnering events, or a frequent participant seeking to optimize their experience, it’s our goal that you have access to learn how to use the platform well, so you can spend more time meeting investors and making deals.

Healthtech Partnering Week (HPW) launches March 15-19, and there’s still time to sign up and even apply for the Innovator’s Pitch Challenge (IPC) – applications are due tomorrow, February 26! If you’re an early stage fundraising executive unsure of what makes a powerful partnering platform, we invite you to watch our latest webinar on strategies for success partnering. Learn more and sign up at https://www.healthtechpartneringweek.com/.

What Successful Partnering Really Looks Like: A Conversation with Neuro20 Technologies

18 Feb

By Rory McCann, Marketing Manager & Conference Producer, LSN

When fundraising executives seek out a successful partnering experience, so many define success with deals and checks. At Life Science Nation, we frequently hear success stories that do end with capital and funding, but many do not. Instead, these stories touch on the benefits of successful partnering that impact company growth and bottom line in other ways, often the details that are taken for granted when seeking strategic partners.

Neuro20 Technologies is one such success story. They attended their first digital RESI conference looking for capital but came out with so much more. Listen to their story, and sign up for RESI (March 15-17) and 4D Meets AI (March 18-19) to learn more from the Neuro20 Technologies team and start your partnering success story!

Last Chance to Apply for the Innovator’s Pitch Challenge

18 Feb

By Joey Wong, Investor Research Analyst, LSN

One of the most powerful features at Healthtech Partnering Week, March 15-19, is the Innovator’s Pitch Challenge. This is a valuable opportunity for fundraising CEOs to showcase their technologies to conference attendees and pitch live to a panel of active investors and industry experts. Each conference throughout the week will host its own Innovator’s Pitch Challenge to ensure best fit for sector and technology. Learn about each conference and determine the best fit for you!

Accepted companies will each be provided with a dedicated landing page on the conference’s Live Agenda, which will host a full-length pitch video, pitch deck, executive summary and any other supplementary materials that are submitted. Companies are also invited to participate in a live Q&A session, which will include a quick elevator pitch, followed by questions and insights from a panel of active investors and industry experts.

This is a valuable opportunity to not only boost exposure among all the conference attendees, but also connect and speak directly with active investors and industry experts in the space. If you are a fundraising CEO, you do not want to miss this opportunity!

The last day to apply for the Innovator’s Pitch Challenge is this Friday, February 19. Be sure to submit your applications before then!

Apply for RESI IPC
March 15 – 17
Apply for 4D Meets AI IPC
March 18 – 19
Apply for LHI IPC
March 18 – 19

Getting it Right from Pitch to Partner

18 Feb

By Karen Deyo, Director of Investor Research, Israel BD, LSN

As each Life Science Nation event approaches, we spend a lot of time and effort to help startups achieve the best possible outcome through partnering. We have published many articles detailing why partnering is important, how to get ready for your outreach, how to get as many meetings as possible and how to prepare for them.

As we gear up to launch Digital RESI partnering next week, we are offering a free tutorial to help founders make the most of the partnering experience. But what steps can you take to make your meeting successful, to improve your chances of a follow up meeting? Here are a few tips that can help!

  1. Know your audience.

We frequently give this advice, both when requesting meetings and when preparing for them. Your meeting will be different, depending on whether you are speaking to a VC, an angel group or a strategic partner. What are they looking for? This can give you the key to making yourself stand out. Make use of online resources to know the investor with whom you are meeting, the organization and their portfolio companies, such as their website, LinkedIn or Crunchbase, among others. The more info you have, the better you can focus on what about your company will spark their interest.

  1. During the meeting, make it a discussion – not a presentation.

In our experience, companies that approach meetings as a discussion with the investor, as opposed to a pitch running through their deck, meet with better responses. Investors see a lot of pitches, and you want to be able to translate your enthusiasm for your company – this does not translate well when simply running through your deck. Engage the investor in a conversation and make it dynamic. However, remember to be grounded: it is important to be passionate, but be realistic about your technology. Not every company is founded on first-in-class science. Improvements to current treatment paradigms can be just as successful and may be more attractive to some investors due to the decreased risk, so don’t oversell yourself.

  1. Know which areas of your company/technology to highlight.

No one knows your company, or your story, better than you. Give the investors a concise (but complete) overview of your company. You know what makes your company stand out, whether it is the story behind the company, the technology, the team, or the application – make sure to highlight this. Also, make sure the investor knows what milestones you have already achieved and, more importantly, how much you are raising and what milestones you plan to hit with these funds.

  1. Know what questions to ask the investor.

The investor will certainly ask you questions that you should be prepared to answer, but you should also think about what questions you want to ask the investor. Gaining an investor is like entering a long-term relationship – you want to make sure that you can work well together, potentially for years to come. In addition, many investors are more than just financial contributors. It is key to find out how involved the investor chooses to be after investing: do they take a board seat? Will they leverage their network or connections for you? For a strategic partner, do they have an infrastructure that could benefit your development? As with the previous tips, this is where knowing your audience can play a big role, as your questions will change depending on the investor. You may ask a traditional VC about their desired timeline to exit, but you would likely ask a Corporate VC about how connected the parent company is to their deals.

The more prepared you are, the greater your chance of success. Fundraising is not only a numbers game, but it can also be a full-time job. By doing what you can to shorten the fundraise, you can increase your time to focus on the most important aspect of your job – building a successful company!

Sign up for our free partnering tutorial, Tuesday, February 23, 12 PM EST.

There is still time to sign up for Healthtech Partnering Week at the early-bird rate. Sign up by February 19 and SAVE!

Healthtech Partnering Week Preliminary Speaker Lineup

11 Feb

By Rory McCann, Marketing Manager & Conference Producer, LSN

Healthtech Partnering Week, March 15-19, is right around the corner! The 5-day digital partnering event consists of three conferences focusing on different areas within life science and healthcare. Redefining Early Stage Investments (RESI) broadly covers investor insights for fundraising executives within healthtech, biotech, and medtech. 4D Meets AI specifically tackles the investor-founder relationship, from pitch to partner, while working with AI technology in drugs, devices, diagnostics, and digital health (4Ds). Longevity, Health & Innovation, co-organized with Mary Furlong & Associates, provides a big-picture approach to the investment ecosystem, as well as market overview and regulatory landscape for early-stage age-tech and innovation enabling seniors to live longer, better lives.

Life Science Nation (LSN) is pleased to introduce our preliminary speaker lineup, featuring investors and industry experts sharing their experiences and offering insights to help fundraising companies succeed in the early stages.

Interested in joining a panel? Visit www.healthtechpartneringweek.com to learn more about each conference. Fundraising in 2021, and looking to meet with active investors? Join us and save on our early-bird rates by February 19!

Featured Healthtech Partnering Week Panelists


Sascha Berger
Partner
TVM Capital Life Science

Diagnostics


Jean Anne Booth
CEO
UnaliWear Inc.

Devices


Nat Brinn
Partner
VC23

Tools and R&D Services


Barbara Clarke
Founder & President
The Impact Seat

Investing in New, Now, and Next


Evan Cohen
Associate Principal, Strategic Investing
Healthbox

Digital Health for the Elderly


Michele Colucci
Managing Partner
DigitalDx Ventures

Diagnostics


Terence Craig
Chief Investment Officer
The Impact Seat

Devices


Bettina Ernst
Director
BERNINA BioInvest

Investing in New, Now, and Next


Howard Fillit
Founding Executive Director and CSO
Alzheimers Drug Discovery Foundation

Early Detection of CNS Disorders


Robert Garber
Partner
7wire Ventures

Investing in New, Now, and Next


Amit Garg
Managing Partner
Tau Ventures

Digital Health


Scott Gazelle
Managing Partner
GreyBird Ventures

Diagnostics


Tom Gibbs
Director
Debiopharm Innovation Fund

Digital Health


Katherine Hill Ritchie
Director
Nottingham Spirk Family Office

Medical Devices


Alicia Irurzun-Lafitte
Partner
UCB Ventures

Cell & Gene Therapy


Justin Kelly
Associate
AXA Venture Partners

Digital Health for the Elderly


Oliver Keown
Director, Intuitive Ventures
Intuitive Surgical

Combination Devices


Lily Kim
Scientific Director
OS Fund

Tools and R&D Services


Kristin King
Member
Boston Harbor Angels

Medical Devices


Richard Kivel
Managing Director
GrayBella Capital

Diagnostics


Daniella Kranjac
Founding Partner
Dynamk Capital

Tools and R&D Services


Taja Lester
Managing Partner
Health Equity Capital

Digital Health for the Elderly


George Li
Managing Partner
Proxima Ventures

Diagnostics


Jonathan Ng
CEO
Iterative Scopes

Digital Health


Jeffrey Ries
Managing Director
Healthbox

Digital Health


Kerry Rupp
General Partner
True Wealth Ventures

Digital Health for the Elderly


Chirag Shah
Principal
Define Ventures

Digital Health


Patrik Sobocki
Investment Manager Life Science
Industrifonden

Digital Health


Catello Somma
Associate
TVM Capital Life Science

Early Stage Therapeutics


Weiyong Sun
Senior Director, Specialty Medicine Search & Evaluation
Daiichi Sankyo

Cell & Gene Therapy


Tad Weems
Managing Director
Agilent Technologies

Tools and R&D Services

%d bloggers like this: